These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1035 related items for PubMed ID: 17130502

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pathogenesis of prediabetes: role of the liver in isolated fasting hyperglycemia and combined fasting and postprandial hyperglycemia.
    Basu R, Barosa C, Jones J, Dube S, Carter R, Basu A, Rizza RA.
    J Clin Endocrinol Metab; 2013 Mar; 98(3):E409-17. PubMed ID: 23345093
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Differences in insulin action and secretion, plasma lipids and blood pressure levels between impaired fasting glucose and impaired glucose tolerance in Japanese subjects.
    Miyazaki Y, Akasaka H, Ohnishi H, Saitoh S, DeFronzo RA, Shimamoto K.
    Hypertens Res; 2008 Jul; 31(7):1357-63. PubMed ID: 18957806
    [Abstract] [Full Text] [Related]

  • 5. Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans.
    Meyer C, Pimenta W, Woerle HJ, Van Haeften T, Szoke E, Mitrakou A, Gerich J.
    Diabetes Care; 2006 Aug; 29(8):1909-14. PubMed ID: 16873801
    [Abstract] [Full Text] [Related]

  • 6. Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance.
    Weyer C, Bogardus C, Pratley RE.
    Diabetes; 1999 Nov; 48(11):2197-203. PubMed ID: 10535454
    [Abstract] [Full Text] [Related]

  • 7. Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose.
    Kanat M, Norton L, Winnier D, Jenkinson C, DeFronzo RA, Abdul-Ghani MA.
    Acta Diabetol; 2011 Sep; 48(3):209-17. PubMed ID: 21553243
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Impaired insulin sensitivity is accompanied by disturbances in skeletal muscle fatty acid handling in subjects with impaired glucose metabolism.
    Moors CC, van der Zijl NJ, Diamant M, Blaak EE, Goossens GH.
    Int J Obes (Lond); 2012 May; 36(5):709-17. PubMed ID: 21712806
    [Abstract] [Full Text] [Related]

  • 12. Pathogenetic mechanisms of impaired glucose tolerance and type II diabetes in African-Americans. The significance of insulin secretion, insulin sensitivity, and glucose effectiveness.
    Osei K, Gaillard T, Schuster DP.
    Diabetes Care; 1997 Mar; 20(3):396-404. PubMed ID: 9051394
    [Abstract] [Full Text] [Related]

  • 13. Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose.
    Festa A, D'Agostino R, Hanley AJ, Karter AJ, Saad MF, Haffner SM.
    Diabetes; 2004 Jun; 53(6):1549-55. PubMed ID: 15161760
    [Abstract] [Full Text] [Related]

  • 14. Change in glucose intolerance status and risk of incident cardiovascular disease: Tehran Lipid and Glucose Study.
    Kabootari M, Hasheminia M, Azizi F, Mirbolouk M, Hadaegh F.
    Cardiovasc Diabetol; 2020 Mar 30; 19(1):41. PubMed ID: 32228577
    [Abstract] [Full Text] [Related]

  • 15. The potential role of the osteopontin-osteocalcin-osteoprotegerin triad in the pathogenesis of prediabetes in humans.
    Daniele G, Winnier D, Mari A, Bruder J, Fourcaudot M, Pengou Z, Hansis-Diarte A, Jenkinson C, Tripathy D, Folli F.
    Acta Diabetol; 2018 Feb 30; 55(2):139-148. PubMed ID: 29151224
    [Abstract] [Full Text] [Related]

  • 16. Insulin secretory dysfunction and insulin resistance in the pathogenesis of korean type 2 diabetes mellitus.
    Kim DJ, Lee MS, Kim KW, Lee MK.
    Metabolism; 2001 May 30; 50(5):590-3. PubMed ID: 11319722
    [Abstract] [Full Text] [Related]

  • 17. Isolated impaired fasting glucose and peripheral insulin sensitivity: not a simple relationship.
    Kim SH, Reaven GM.
    Diabetes Care; 2008 Feb 30; 31(2):347-52. PubMed ID: 18000184
    [Abstract] [Full Text] [Related]

  • 18. Individuals With Prediabetes Display Different Age-Related Pathophysiological Characteristics.
    Fiorentino TV, Pedace E, Succurro E, Andreozzi F, Perticone M, Sciacqua A, Perticone F, Sesti G.
    J Clin Endocrinol Metab; 2019 Jul 01; 104(7):2911-2924. PubMed ID: 30848793
    [Abstract] [Full Text] [Related]

  • 19. Glucoregulatory physiology in subjects with low-normal, high-normal, or impaired fasting glucose.
    Dagogo-Jack S, Askari H, Tykodi G.
    J Clin Endocrinol Metab; 2009 Jun 01; 94(6):2031-6. PubMed ID: 19276238
    [Abstract] [Full Text] [Related]

  • 20. Incretin action maintains insulin secretion, but not hepatic insulin action, in people with impaired fasting glucose.
    Perreault L, Man CD, Hunerdosse DM, Cobelli C, Bergman BC.
    Diabetes Res Clin Pract; 2010 Oct 01; 90(1):87-94. PubMed ID: 20708814
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 52.